Logo-jpd
J parathyr dis. 2016;4(2): 34-35.
  Abstract View: 1163
  PDF Download: 532

Editorial

FGF 23 and cardiovascular outcome in chronic kidney disease
 

Farrokhlagha Ahmadi 1*

1 Division of Nephrology, Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
*Corresponding Author: *Corresponding author: Prof. Farrokhlagha Ahmadi, , Email: ahmadifa@sina.tums.ac.ir

Implication for health policy/practice/research/medical education
A high level of fibroblast growth factor-23 (FGF-23) is the initial abnormality of mineral metabolism in chronic kidney disease (CKD). Results of several studies indicate a relation between FGF23 and LVH. Cardiovascular disease is an important cause of death in patients with CKD and elevated FGF-23 is a strong predictor of mortality. Additionally, FGF23 was independently connected to an increased risk for cardiovascular mortality in individuals with renal failure with manifest coronary artery disease.

Please cite this paper as: Ahmadi F. FGF 23 and cardiovascular outcome in chronic kidney disease. J Parathyr Dis. 2016;4(2):34-35.​

 
 
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1164

Your browser does not support the canvas element.


PDF Download: 532

Your browser does not support the canvas element.

ePublished: 12 Mar 2016
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)